[Conservative treatment concepts for stable angina pectoris in coronary heart disease].

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Medizinische Klinik

• Publication date

  1996-07-15

• Fields of study

  Medicine

• Identifiers
  PMID 8756115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?].

  2008cited by this paper
• Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

  1995cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• [Therapy-refractory angina pectoris. Pathophysiologic basis and evaluation of alternative therapies].

  1995cited by this paper
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.

  1994cited by this paper
• Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.

  1994cited by this paper
• Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.

  1994cited by this paper
• Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium.

  1993cited by this paper
• Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.

  1993cited by this paper
• The mechanism of myocyte death in ischaemia.

  1993cited by this paper
• Beneficial Effect of Carnitine on Mechanical Recovery of Rat Hearts Reperfused After a Transient Period of Global Ischemia Is Accompanied by a Stimulation of Glucose Oxidation

  1993cited by this paper
• The Role of Nitric Oxide in Endothelium‐Dependent Vasodilation of Hypercholesterolemic Patients

  1993cited by this paper
• Influence of Serum Cholesterol and Other Coronary Risk Factors on Vasomotion of Angiographically Normal Coronary Arteries

  1993cited by this paper
• Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease

  1993cited by this paper
• Myocardial cytoprotection during percutaneous transluminal coronary angioplasty.

  1993cited by this paper
• [Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease

  1992cited by this paper
• Controlled study on L-carnitine therapeutic efficacy in post-infarction.

  1992cited by this paper
• Long-term experience with lovastatin treatment in patients with coronary heart disease and hyperlipoproteinaemia type II.

  1992cited by this paper
• The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study.

  1991cited by this paper
• The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria

  1991cited by this paper
• Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.

  1991cited by this paper
• Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.

  1991cited by this paper
• [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].

  1991cited by this paper
• Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study

  1990cited by this paper
• Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

  1990cited by this paper
• Propionyl carnitine in stable effort angina

  1990cited by this paper
• Influence of trimetazidine on deleterious effect of oxygen radical species in post-ischemic acute renal failure in the rat

  1990cited by this paper
• Stable angina pectoris: 3. Medical treatment.

  1990cited by this paper
• Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

  1990cited by this paper
• Medical therapy of chronic stable angina pectoris.

  1990cited by this paper
• Silent myocardial ischemia.

  1989cited by this paper
• New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects.

  1989cited by this paper
• Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris.

  1989cited by this paper
• Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.

  1988cited by this paper
• Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris.

  1988cited by this paper
• Total ischemic burden: pathophysiology and prognosis.

  1987cited by this paper
• Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT).

  1987cited by this paper
• Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study.

  1987cited by this paper
• Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination.

  1986cited by this paper
• Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease.

  1985cited by this paper
• Improved coronary supply: prevailing mechanism of action of nitrates in chronic stable angina.

  1985cited by this paper
• Mixed angina pectoris.

  1985cited by this paper
• Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.

  1985cited by this paper
• Survival following coronary artery bypass grafting in patients with severe angina pectoris (CASS). An observational study.

  1985cited by this paper
• "Maximal" drug therapy is not necessarily optimal in chronic angina pectoris.

  1984cited by this paper
• Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.

  1983cited by this paper
• Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.

  1983cited by this paper
• Verapamil therapy for stable exertional angina pectoris.

  1982cited by this paper
• Prognostic importance of anginal symptoms in angiographically defined coronary artery disease.

  1981cited by this paper
• Angina pectoris and the placebo effect.

  1979cited by this paper
• Protective effect of propranolol in threatened myocardial infarction.

  1978cited by this paper
• Letter: Grading of angina pectoris.

  1976cited by this paper
• Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.

  1975cited by this paper

• [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy].

  1997cites this paper
• Konservative Therapieansätze bei terminaler koronarer Herzkrankheit

  1997cites this paper
• [Coronary vasomotion in coronary heart disease--significance of epicardial and microcirculatory vessels for myocardial perfusion].

  1997cites this paper
• [Indications and limits of conventional revascularization methods in coronary heart disease].

  1997cites this paper